---
title: "Aprea Therapeutics, Inc. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/4a07e81e-7894-5160-afdf-6de06bddeb11
json: https://whiteintel.dev/api/public/dossier/4a07e81e-7894-5160-afdf-6de06bddeb11
identifier: sec:0001781983
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Aprea Therapeutics, Inc.

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001781983`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/4a07e81e-7894-5160-afdf-6de06bddeb11  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/4a07e81e-7894-5160-afdf-6de06bddeb11  

## Ownership & control

### Owners / controllers

- **Redmile Group, LLC** (tenpercentowner) — https://whiteintel.dev/entity/4d5d139b-079d-5f97-a23d-55867544d098
- **Green Jeremy** (tenpercentowner) — https://whiteintel.dev/entity/9a44ab54-8a62-5436-912e-17661f2862a3
- **KDEV INVESTMENTS AB** (tenpercentowner) — https://whiteintel.dev/entity/f06f3d19-1c2a-5e3c-a5fb-7721c029bf0d
- **KCIF CO-INVESTMENT FUND KB** (tenpercentowner) — https://whiteintel.dev/entity/87aa01b5-4f22-5cb9-83f4-3268db523d5f
- **KAROLINSKA DEVELOPMENT AB** (tenpercentowner) — https://whiteintel.dev/entity/1dc6e328-86c3-52d8-8cb7-e1d9516d961a
- **Versant Vantage I, L.P.** (tenpercentowner) — https://whiteintel.dev/entity/8f0e2021-c060-5361-acde-481dc0ca7552
- **5AM PARTNERS IV, LLC** (tenpercentowner) — https://whiteintel.dev/entity/17d2f75e-ab72-5ae6-bbaf-2c722ab55b2f
- **Versant Vantage I GP, L.P.** (tenpercentowner) — https://whiteintel.dev/entity/8db2ca8e-3702-54d7-8ed0-1bcaa3799b60
- **VERSANT V LUXCO S.A R.L.** (tenpercentowner) — https://whiteintel.dev/entity/f7566306-9a84-523f-8722-5ac948e27578
- **5AM VENTURES IV, L.P.** (tenpercentowner) — https://whiteintel.dev/entity/4b181f9a-e151-568a-bb0d-5337566539d1
- **VERSANT VENTURE CAPITAL V (CANADA), LP** (tenpercentowner) — https://whiteintel.dev/entity/b1e67d5b-c36a-52af-afdd-3204784e4f70
- **DIEKMAN JOHN D** (tenpercentowner) — https://whiteintel.dev/entity/354fa538-2f56-5901-a4ca-d53b41a4bdca
- **Versant Vantage I GP-GP, LLC** (tenpercentowner) — https://whiteintel.dev/entity/20b84e21-b0c6-59f8-8ca4-2bcda7181757
- **ROCKLAGE SCOTT M** (tenpercentowner) — https://whiteintel.dev/entity/d6df5162-fc9f-58ff-8e74-b0f4b2b6ea81
- **VERSANT VENTURE CAPITAL V, L.P.** (tenpercentowner) — https://whiteintel.dev/entity/706b5e9f-3fcb-5005-ae83-50d1b41695c9
- **5AM CO-INVESTORS IV, L.P.** (tenpercentowner) — https://whiteintel.dev/entity/2f7ca1e1-82b2-5c5f-94d7-25211397634d
- **5AM OPPORTUNITIES I, L.P.** (tenpercentowner) — https://whiteintel.dev/entity/e305afdd-db33-5984-ba83-b25dc96af911
- **VERSANT VENTURES V, LLC** (tenpercentowner) — https://whiteintel.dev/entity/ab895a73-3e64-5f53-9b55-bddbd3989e5b
- **VERSANT AFFILIATES FUND V, L.P.** (tenpercentowner) — https://whiteintel.dev/entity/bb7dfac2-c135-5fed-8337-344f1fb14778
- **VERSANT VENTURES V (CANADA), L.P.** (tenpercentowner) — https://whiteintel.dev/entity/41aca41b-68a2-5c01-9dfb-c70a9619667a
- **VERSANT OPHTHALMIC AFFILIATES I, L.P.** (tenpercentowner) — https://whiteintel.dev/entity/4eb10f3b-a5f4-57cf-84ff-677d1131dcc1
- **PARMAR KUSH** (tenpercentowner) — https://whiteintel.dev/entity/065f8e99-fc9e-57aa-9f03-d3f847f115e2
- **Schwab Andrew J.** (tenpercentowner) — https://whiteintel.dev/entity/8f30801b-d5eb-51c9-919f-44e2852ff52d
- **5AM OPPORTUNITIES I (GP), LLC** (tenpercentowner) — https://whiteintel.dev/entity/b677aeec-1868-5646-9ba3-9c059fff87a8
- **HEALTHCAP VII GP S.A.** (tenpercentowner) — https://whiteintel.dev/entity/e1f05fbe-a080-5053-963e-12f27306c910
- **HEALTHCAP VII, L.P.** (tenpercentowner) — https://whiteintel.dev/entity/12885f7a-5392-5dab-8958-d04c29914fbe
- **VERSANT VENTURES V GP-GP (CANADA), INC.** (tenpercentowner) — https://whiteintel.dev/entity/852baacf-3cac-59f6-bbc6-cc446c593795

### UBO chain (walk to the ultimate owner)

A **66-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **Aprea Therapeutics, Inc.** — https://whiteintel.dev/entity/4a07e81e-7894-5160-afdf-6de06bddeb11 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Aprea Therapeutics, Inc.**. Human view: https://whiteintel.dev/entity/4a07e81e-7894-5160-afdf-6de06bddeb11 · Structured JSON: https://whiteintel.dev/api/public/dossier/4a07e81e-7894-5160-afdf-6de06bddeb11._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._